Human Normal Immunoglobulin is indicated for Primary immunodeficiency disorders Secondary immunodeficiencies, Immune thrombocytopenic purpura (ITP), Chronic inflammatory demyelinating polyneuropathy (CIDP), Prevention of infections in immunocompromised patients, Replacement therapy in patients with hypogammaglobulinemia.

Common side effects may include: Headache, Fever, Chills, Fatigue, Nausea and Allergic reactions (e.g., rash or anaphylaxis in rare cases)

HUMAN NORMAL IMMUNOGLOBULIN should be used with caution in people with obesity or overweight, diabetes, high blood pressure (hypertension), hypovolemia (low blood volume), and blood clotting disorders, as there is a risk of developing a blood clot.

Human Normal Immunoglobulin is contraindicated in Individuals with known hypersensitivity to immunoglobulins or any of its components and Patients with hyperprolinemia or renal impairment without adequate monitoring.

As directed by physician.

Human Normal Immunoglobulin is available in many countries, including LATAM, European Union member countries, Australia, India, and Various countries in Asia and Africa.

Human Normal Immunoglobulin is available in the following forms: intravenous (IV) solution, which is typically available in vials or bags for infusion, and Subcutaneous (SC) solution, which is available in pre-filled syringes or vials for home administration.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai.